FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1650482070> ?p ?o ?g. }

• W1650482070 abstract "The goal of this study was to investigate the function of the heat shock protein 70 family members, expressed in tumors under physiological and stress conditions and to dissect their role in tumor immune recognition as a function of intra- versus extracellular location. Another goal was to investigate whether heat-treatment at clinically relevant thermal doses affects the immunophenotype of a given tumor, as defined by tumor cell sensitivity to immune effector cells. For these questions, the human melanoma system was selected because it is well characterized with regards to tumor-associated antigens, like tyrosinase and Melan-A/MART-1, their epitopes and restriction elements for MHC class I presentation. In the first part of the study the focus specifically was on the time-temperature dependent effects of heat exposure. Two different thermal doses (41,8°C/120 minutes and 45°C/22 minutes) were selected that mimic the heterogeneity of the achieved temperature distribution within the tumor and the time-temperature dependent changes were determined in: a) antigen expression (tyrosinase and Melan-A/MART-1) at the protein and mRNA level; b) expression of the inducible HSP70 and the constitutive HSC70; c) processing and presentation of tyrosinase and MART-1 via MHC class I; d) susceptibility of melanoma cell lines to cytotoxic T lymphocytes like CD8+ T cells, LAK and NK cells. It was demonstrated that HSP70 and antigen expression display distinct expression and kinetics that reflect the thermohistory of the cells, i.e. exposure to high or low thermal doses. Immunologically, a low thermal dose did not alter immune recognition of the cells despite the fact that intracellular HSP70 and tyrosinase protein were upregulated. High thermal dose induced a pleiotropy of effects, including stronger upregulation of HSP70 and tyrosinase protein but downregulation of tyrosinase at mRNA level. Concordant with reduced HLA-A2 surface expression and tyrosinase mRNA levels, immune recognition of the heat-treated cells was initially reduced, but pretreatment levels were restored after 72 hours of recovery. The observation that tumor cells treated with temperatures below the breakpoint temperature maintain an immunological homeostasis during the heat shock response is of critical importance for the clinical application of hyperthermia in the treatment of tumors. In the second part of the study, the ability of HSP70 to cross-present a naturally expressed human tumor antigen, tyrosinase, that is of low immunigenicity, a situation that more closely resembles the patient situation was investigated. It was demonstrated that HSP70-peptide complexes (HSP70-PC) purified from tyrosinase-positive (HSP70-PC/tyr+) but not from tyrosinase-negative (HSP70-PC/tyr-) melanoma cells deliver the tyrosinase antigen to immature DCs for MHC class I restricted T cell recognition. T cell stimulation by HSP70-PC/tyr+ incubated with immature DCs with was very efficient even without additional DC maturation signals (e.g. exogenous TNF-?) demonstrating the ability of tumor-derived HSP70-PC to act as a chaperone for peptides and a signal for DC maturation. HSP70-PC in exerting both functions on DCs, delivering antigens and maturing DCs, ensures that the peptides that are delivered to the DCs are presented in an immunogenic context optimal for T cell stimulation. In conlusion, induction of intracellular heat shock proteins (HSPs) by heat does not interfere with the tumor immune recognition and when HSPs are expressed extracellularly they acquire immunostimulatory properties. These observations open new perspectives for the application of hyperthermia in combination with HSP-based vaccine in the treatment of solid tumors." @default.
• W1650482070 created "2016-06-24" @default.
• W1650482070 creator A5085688218 @default.
• W1650482070 date "2005-01-13" @default.
• W1650482070 modified "2023-09-24" @default.
• W1650482070 title "Effects of intracellular and extracellular heat shock proteins on anti-tumor immune responses" @default.
• W1650482070 cites W11411359 @default.
• W1650482070 cites W1483162601 @default.
• W1650482070 cites W1515599953 @default.
• W1650482070 cites W1525721830 @default.
• W1650482070 cites W1531083656 @default.
• W1650482070 cites W1550722415 @default.
• W1650482070 cites W1551798452 @default.
• W1650482070 cites W1558109280 @default.
• W1650482070 cites W1567327455 @default.
• W1650482070 cites W1573148785 @default.
• W1650482070 cites W1574881121 @default.
• W1650482070 cites W1588132881 @default.
• W1650482070 cites W1589492089 @default.
• W1650482070 cites W1592589742 @default.
• W1650482070 cites W1604363681 @default.
• W1650482070 cites W1607689059 @default.
• W1650482070 cites W1655860314 @default.
• W1650482070 cites W1661544713 @default.
• W1650482070 cites W1675195038 @default.
• W1650482070 cites W1736132406 @default.
• W1650482070 cites W1775749144 @default.
• W1650482070 cites W1782287000 @default.
• W1650482070 cites W1836178690 @default.
• W1650482070 cites W1887940719 @default.
• W1650482070 cites W1903646257 @default.
• W1650482070 cites W1925735392 @default.
• W1650482070 cites W1963770237 @default.
• W1650482070 cites W1965517166 @default.
• W1650482070 cites W1968134126 @default.
• W1650482070 cites W1969586917 @default.
• W1650482070 cites W1971521446 @default.
• W1650482070 cites W1977007393 @default.
• W1650482070 cites W1977058664 @default.
• W1650482070 cites W1977298268 @default.
• W1650482070 cites W1977812921 @default.
• W1650482070 cites W1981654979 @default.
• W1650482070 cites W1985782120 @default.
• W1650482070 cites W1986910064 @default.
• W1650482070 cites W1987074547 @default.
• W1650482070 cites W1989030517 @default.
• W1650482070 cites W1989770318 @default.
• W1650482070 cites W1990772742 @default.
• W1650482070 cites W1991464867 @default.
• W1650482070 cites W1992847016 @default.
• W1650482070 cites W1996617163 @default.
• W1650482070 cites W1997044852 @default.
• W1650482070 cites W1997390346 @default.
• W1650482070 cites W1999727030 @default.
• W1650482070 cites W2001015172 @default.
• W1650482070 cites W2002704444 @default.
• W1650482070 cites W2003563101 @default.
• W1650482070 cites W2007898062 @default.
• W1650482070 cites W2010457947 @default.
• W1650482070 cites W2013024855 @default.
• W1650482070 cites W2013573914 @default.
• W1650482070 cites W2017407711 @default.
• W1650482070 cites W2018728670 @default.
• W1650482070 cites W2019505133 @default.
• W1650482070 cites W2032942842 @default.
• W1650482070 cites W2038545704 @default.
• W1650482070 cites W2041020348 @default.
• W1650482070 cites W2041696131 @default.
• W1650482070 cites W2042411369 @default.
• W1650482070 cites W2044853699 @default.
• W1650482070 cites W2046377038 @default.
• W1650482070 cites W2047003662 @default.
• W1650482070 cites W2047761607 @default.
• W1650482070 cites W2051940153 @default.
• W1650482070 cites W2052069700 @default.
• W1650482070 cites W2053021234 @default.
• W1650482070 cites W2054626405 @default.
• W1650482070 cites W2055730705 @default.
• W1650482070 cites W2056737552 @default.
• W1650482070 cites W2058352235 @default.
• W1650482070 cites W2058653058 @default.
• W1650482070 cites W2059686157 @default.
• W1650482070 cites W2059950129 @default.
• W1650482070 cites W2062181819 @default.
• W1650482070 cites W2062810159 @default.
• W1650482070 cites W2065367621 @default.
• W1650482070 cites W2066562421 @default.
• W1650482070 cites W2068081396 @default.
• W1650482070 cites W2071192671 @default.
• W1650482070 cites W2071272710 @default.
• W1650482070 cites W2072861830 @default.
• W1650482070 cites W2074199513 @default.
• W1650482070 cites W2075117403 @default.
• W1650482070 cites W2080335579 @default.
• W1650482070 cites W2081673421 @default.
• W1650482070 cites W2083492551 @default.
• W1650482070 cites W2083682196 @default.
• W1650482070 cites W2084383983 @default.
• W1650482070 cites W2085432787 @default.
• W1650482070 cites W2089495593 @default.

• next